The blood test Colox® is designed for accurate and reliable detection of adenoma and early stage colorectal cancer. It offers a convenient solution for patients to be tested with no need for bowel or stool preparation. It can be ordered by the physician as part of a routine medical check-up.
BASED ON THE TUMOR-HOST INTERACTION
Colox® is a molecular test that measures the immune system reaction to the onset of colorectal cancer. The test analyses the transcriptome of peripheral blood mononuclear cells (PBMCs) isolated from a blood sample. PBMCs are changing their transcriptomic profiles in presence of growing adenoma and colorectal carcinoma as part of the “host-response”.